Loss of epidermal langerhans cells occurs in human papillomavirus α, γ, and but not β genus infections

Journal of Investigative Dermatology

Volumn 130, Issue 2, 2010, Pages 472-480

  Leong, Cheng Mee ^a   Doorbar, John ^b   Nindl, Ingo ^c   Yoon, Han Seung ^a   Hibma, Merilyn H ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN PAPILLOMAVIRUS ALPHA; HUMAN PAPILLOMAVIRUS BETA; HUMAN PAPILLOMAVIRUS GAMMA; HUMAN PAPILLOMAVIRUS MU; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LANGERHANS CELL; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS INFECTION;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; BIOPSY; CONDYLOMATA ACUMINATA; EPIDERMIS; HUMANS; IMMUNE SYSTEM; LANGERHANS CELLS; MUCOUS MEMBRANE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK; T-LYMPHOCYTES, REGULATORY;

EID: 75549088610     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.266     Document Type: Article

References (21)

1. Brink AA, Lloveras B, Nindl I, Heideman DA, Kramer D, Pol R et al. (2005) Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 43:5581-5587
2. Caberg JH, Hubert P, Herman L, Herfs M, Roncarati P, Boniver J et al. (2009) Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother 58:39-47
3. Caberg JH, Hubert PM, Begon DY, Herfs MF, Roncarati PJ, Boniver JJ et al. (2008) Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcino-genesis 29:1441-1447
4. Cao Y, Zhao J, Lei Z, Shen S, Liu C, Li D et al. (2008) Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata. J Immunol 180:7681-7686
5. Cooper KD, Androphy EJ, Lowy D, Katz SI (1990) Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 94:769-776
6. de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ et al. (2004) Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 64:5449-5455
7. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17-27
8. Dell'Oste V, Azzimonti B, De Andrea M, Mondini M, Zavattaro E, Leigheb G et al. (2009) High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 129:1026-1034
9. Dillon S, Sasagawa T, Crawford A, Prestidge J, Inder MK, Jerram J et al. (2007) Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2. J Gen Virol 88:803-813
10. Fausch SC, Fahey LM, Da Silva DM, Kast WM (2005) Human papillomavirus can escape immune recognition through Langerhans cell phosphoinosi-tide 3-kinase activation. J Immunol 174:7172-7178
11. Guess JC, McCance DJ (2005) Decreased migration of Langerhans precursorlike cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 79:14852-14862
12. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, Jiang S et al. (2007) Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27: 610-624
13. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A et al. (2006) Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98:389-395
14. Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, Thomson AW et al. (2001) Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2:1151-1158
15. Matthews K, Leong CM, Baxter L, Inglis E, Yun K, Backstrom BT et al. (2003) Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J Virol 77:8378-8385
16. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I et al. (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135-1141
17. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T et al. (2003) Organization of human papillomavirus productive cycle during neo-plastic progression provides a basis for selection of diagnostic markers. J Virol 77:10186-10201
18. Peh WL, Middleton K, Christensen N, Nicholls P, Egawa K, Sotlar K et al. (2002) Life cycle heterogeneity in animal models of human papilloma-virus- associated disease. J Virol 76:10401-10416
19. Pfister H (2003) Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31:52-56
20. Rubben A, Kalka K, Spelten B, Grussendorf-Conen EI (1997) Clinical features and age distribution of patients with HPV 2/27/57-induced common warts. Arch Dermatol Res 289:337-340
21. Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J et al. (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 125:93-97